By Elisabeth Dostert
The coronavirus vaccine made the Mainz company Biontech famous. The next fight will be more difficult because the enemy is more treacherous: it is malaria, several hundred thousand people still die from the disease every year. Biontech wants a “safe, highly effective and well-tolerated vaccine” against malaria with “longer lasting immunity” – this is how the story of the corona vaccine began. The same technology is used: mRNA. The start of clinical studies is scheduled for the end of 2022.